Depression and stimulant dependence: Neurobiology and pharmacotherapy

Journal of Nervous and Mental Disease

Volumn 186, Issue 12, 1998, Pages 737-745

  Kosten, Thomas R ^a   Markou, Athina ^b   Koob, George F ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; NEUROPEPTIDE Y; OPIATE; PEPTIDE; SEROTONIN;

ALCOHOLISM; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG WITHDRAWAL; GENETIC LINKAGE; HERITABILITY; HUMAN; LIMBIC CORTEX; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROTRANSMISSION;

ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CLINICAL TRIALS; COMORBIDITY; DEPRESSIVE DISORDER; DOPAMINE; HUMANS; LIMBIC SYSTEM; MULTICENTER STUDIES; NEUROTRANSMITTER AGENTS; RESEARCH DESIGN; SEROTONIN; SUBSTANCE-RELATED DISORDERS;

EID: 0031673783     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199812000-00001     Document Type: Article

References (129)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed). Washington, DC: Author.
2. Anthony JC, Helzer JE (1991) Syndromes of drug abuse and dependence. In LN Robins, DA Regier (Eds), Psychiatric disorders in America: The Epidemiologic Catchment Area Study (pp 116-154). New York: The Free Press.
3. Arato M, Banki CM, Bissette G, Nemeroff CB (1989) Elevated CSF CRF in suicide victims. Biol Psychiatry 25:355-359.
4. Arndt IO, Dorozynsky L, Woody GE, McLellan AT, O'Brien CP (1992) Desipramine treatment of cocaine dependence in methadone-maintenance patients. Arch Gen Psychiatry 49:888-893.
5. Batki SL (1988) Treatment of intravenous drug users with AIDS: The role of methadone maintenance. J Psychoactive Drugs 20: 213-216.
6. Batki SL, Washburn AM, Delucchi K, Jones RT (1996) A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 41:137-142.
7. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.
8. Benloucif S, Keegan MJ, Galloway MP (1993) Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J Pharmacol Exp Ther 265:373-377.
9. Best SE, Malison RT, Wallace EA, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Innis RB, Kosten TR (1994) SPECT imaging of the dopamine transporter in cocaine abstinence: Preliminary studies using [123-I]b-CIT. In LS Harris (Ed), Problems of drug dependence, 1994. National Institute on Drug Abuse Research Monograph 153, Washington, DC: Supt. of Docs., U.S. Govt. Print. Off.
10. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226.
11. Bokstrom K, Balldin J (1992) A rating scale for assessment of alcohol withdrawal psychopathology (AWIP). Alcohol Clin Exp Res 16:241-249.
12. Branchey L, Branchey M, Shaw S, Lieber CS (1984) Relationship between changes in plasma amino acids and depression in alcoholic patients. Am J Psychiatry 141:1212-1215.
13. Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, Rohsenow DJ (1998) Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 155:220-225.
14. Brown SA, Schuckit MA (1988) Changes in depression among abstinent alcoholics. J Stud Alcohol 49:412-417.
15. Cadoret RJ, O'Gorman TW, Heywood E, Troughton E (1985) Genetic and environmental factors in major depression. J Affect Disord 9:155-164.
16. Carroll KM, Nich C, Rounsaville BJ (1995) Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis 183:251-259.
17. Carroll KM, Power ME, Bryant K, Rounsaville BJ (1993) One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 181:71-79.
18. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FW (1994) Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 51:177-187.
19. Ciraulo DA, Jaffe JH (1981) Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharmacol 1:146-150.
20. Cloninger CR, Reich T, Wetzel R (1979) Alcoholism and affective disorders: Familial associations and genetic models. In DW Goodwin, CK Erickson (Eds), Alcoholism and affective disorders: Clinical, genetic and biochemical studies (pp. 57-86). New York: SP Medical and Scientific Books.
21. Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237-1264.
22. Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ (1995) Preliminary report: Double-blind, placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacol Bull 31:297-303.
23. Covi L, Hess JM, Kreiter NA, Haertzen CA (1995) Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 21:327-344.
24. Dackis CA, Pottash ALC, Gold MS, Annitto W (1984) The dexamethasone suppression test of major depression among opiate addicts. Am J Psychiatry 141:810-811.
25. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian, GK, Heninger GR, Charney DS (1994) Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51:865-874.
26. de Montigny C, Aghajanian GK (1978) Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303-1306.
27. Deykin EY, Buka SL, Zeena TH (1992) Depressive illness among chemically dependent adolescents. Am J Psychiatry 149: 1341-1347.
28. France RD, Urban B, Krishnan KRR, Bissett G, Banki CM, Nemeroff C, Speilman FJ (1988) CSF corticotropin-releasing factor-like immunoreactivity in chronic pain patients with and without major depression. Biol Psychiatry 23:86-88.
29. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D (1994) Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 13:201-216.
30. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113.
31. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117-121.
32. Gjerris A, Widerlov E, Werdelin L, Ekman R (1992) Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci 17:23-27.
33. Goeders NE, Bienvenu OJ, DeSouza EB (1990) Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 531:322-328.
34. Goodwin DW (1992) Alcohol: Clinical aspects in substance abuse. In JH Lowinson, P Ruiz, RB Millman (Eds), Substance abuse: A comprehensive textbook (pp 144-151). Baltimore: Williams & Wilkins.
35. Goodwin DW, Schulsinger F, Hermansen L, Guze SB, Winokur G (1973) Alcohol problems in adoptees raised apart from alcoholic biological parents. Arch Gen Psychiatry 28:238-243.
36. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled double-blind trials. J Clin Psychopharmacol 15:163-174.
37. Gurling HMD, Oppenheim BE, Murray RM (1984) Depression, criminality and psychopathology associated with alcoholism: Evidence from a twin study. Acta Genet Med Gemellol 33:333-339.
38. Harrington R, Fudge H, Rutter M, Pickles A, Hill J (1990) Adult outcomes of childhood and adolescent depression: I. Psychiatric status. Arch Gen Psychiatry 47:465-473.
39. Heilig M, Koob GF, Ekman R, Britton KT (1994) Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends Neurosci 17:80-85.
40. Heilig M, Widerlov E (1990) Neuropeptide Y: An overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr Scand 82: 95-114.
41. Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995) Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6:74-80.
42. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195-1202.
43. Janowsky A, Okada F, Manier, DH, Applegate CD, Sulser F, Steranka LR (1982) Role of serotonergic input in the regulation of the beta-adrenergic receptor-coupled adenylate cyclase system. Science 218:900-901.
44. Jimerson DC (1987) Role of dopamine mechanisms in the affective disorders. In HY Meltzer (Ed), Psychopharmacology: The third generation of progress (pp 505-511). New York: Raven Press.
45. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ (1993) Alcoholism and major depression in women: A twin study of the causes of comorbidity. Arch Gen Psychiatry 50:690-698.
46. Kendler, KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ (1995) The structure of the genetic and environmental risk factors for six major psychiatric disorders in women: Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52: 374-383.
47. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
48. Khantzian EJ (1985) The self medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 142:1259-1264.
49. Kilbey MM, Breslau N, Andreski P (1992) Cocaine use and dependence in young adults: Associated psychiatric disorders and personality traits. Drug Alcohol Depend 29:283-290.
50. Heber HD, Weissman MM, Rounsaville BJ, Wilber CH, Prusoff BA, Riordan CE (1983) Imipramine as treatment for depression in addicts. Arch Gen Psychiatry 40:649-653.
51. Kleinman PH, Miller AB, Millman RB, Woody GE, Todd T, Kemp J, Lipton DS (1990) Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis 178:442-447.
52. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
53. Koob GF, Caine B, Markou A, Pulvirenti L, Weiss F (1994) Role for the mesocortical dopamine system in the motivating effects of cocaine. In LS Harris (Ed), Problems of drug dependence, 1994. National Institute on Drug Abuse Research Monograph 148:1-18, Washington, DC: Supt. of Docs., U.S. Govt. Print. Off.
54. Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. In JM Liebman, SJ Cooper (Eds), The neuropharmacological basis of reward (pp 214-263). New York: Oxford University Press.
55. Koob GF, Markou A, Weiss F, Schulteis G (1993) Opponent process and drug dependence: Neurobiological mechanisms. Semin Neurosci 5:351-358.
56. Koob GF, Weiss F (1992) Neuropharmacology of cocaine and ethanol dependence. In M Galanter (Ed), Recent developments in alcoholism, Volume 10: Alcohol and cocaine: Similarities and differences (pp 201-233). New York: Plenum Press.
57. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS (1992) Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 49:894-898.
58. Kranzler HR, Wallington DJ (1992) Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients. Am J Drug Alcohol Abuse 18:187-195.
59. Lin N, Eisen SA, Scherrer JF, Goldberg J, True WR, Lyons MJ, Tsuang MT (1996) The influence of familial and non-familial factors on the association between major depression and substance abuse/dependence in 1874 monozygotic male twin pairs. Drug Alcohol Depend 43:49-55.
60. Linnoila M, Virkkunen M, George T, Eckardt M, Higley JD, Nielsen D, Goldman D (1994) Serotonin, violent behavior and alcohol. EXS 71:155-163.
61. Liskow BI, Goodwin DW (1987) Pharmacological treatment of alcohol intoxication, withdrawal and dependence: A critical review. J Stud Alcohol 48:356-370.
62. 123I]β-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology 122: 358-362.
63. Manier DH, Gillespie DD, Steranka LR, Sulser F (1984) A pivotal role of serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: Reversibility of the action of parachlorophenylalamine by 5-hydroxytryptophan. Experientia 40:1223-1226.
64. Manier DH, Gillespie DD, Sulser F (1987) 5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: A reevaluation. Biochem Pharmacol 36:3308-3310.
65. Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, Ascher JA, Li SH, Bridge P (1995) A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 40:125-131.
66. Markou A, Koob GF (1991) Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology 4: 17-26.
67. Markou A, Kosten TR, Koob GF (1998) Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 18:135-174.
68. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275:761-767.
69. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, Quitkin FM (1996) Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Arch Gen Psychiatry 53:232-240.
70. McIntyre IM, Oxenkrug GF (1984) Chronic alcohol administration increases corticosterone resistance to suppression by dexamethasone. Biol Psychiatry 19:1725-1729.
71. Meltzer HY, Lowy MT (1987) The serotonin hypothesis of depression. In HY Meltzer (Ed), Psychopharmacology: The third generation of progress (pp 513-527). New York: Raven Press.
72. Mendelson JH, Teoh S, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J (1988) Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry 145: 1094-1098.
73. Merikangas KR, Gelernter CS (1990) Comorbidity for alcoholism and depression. Psychiatr Clin North Am 13:613-632.
74. Myers JK, Weissman MM, Tischler GL, Holzer CE, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD, Kramer M, Stoltzman R (1984) Six-month prevalence of psychiatric disorders in three communities: 1980 to 1982. Arch Gen Psychiatry 41:959-967.
75. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin releasing factor-binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45: 577-579.
76. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
77. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1991) Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195:63-73.
78. Nunes EV, McGrath PJ, Quitkin FM, Ocepek-Welikson K, Stewart JW, Koenig T, Wager S, Klein DF (1995) Imipramine treatment of cocaine abuse: Possible boundaries of efficacy. Drug Alcohol Depend 39:185-195.
79. Nunes EV, McGrath PJ, Quitkin FM, Stewart JP, Harrison W, Tricamo E, Ocepek-Welikson K (1993) Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 150:963-965.
80. Nunes EV, Quitkin FM, Brady R, Post-Koenig T (1994) Antidepressant treatment in methadone maintenance patients. J Addict Dis 13:13-24.
81. Nunes EV, Quitkin FM, Brady R, Stewart JW (1991) Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use. Am J Psychiatry 148:667-669.
82. Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, Woody G (1998) Imipramine treatment of opiate-dependent patients with depressive disorders: A placebo-controlled trial. Arch Gen Psychiatry 55:153-160.
83. Olivera AA, Fero D, Scibilia J (1991) Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence. Am J Drug Alcohol Abuse 17:295-305.
84. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-173.
85. Parsons LH, Justice JR (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195-199.
86. Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274:1182-1191.
87. Parsons LH, Smith AD, Justice JB Jr (1991) Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65.
88. 2 receptors after antidepressant administration in the forced swim test and other chronic antidepressant drug treatment. J Pharmacol Exp Ther 246: 956-962.
89. Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88-90.
90. Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Clayton PJ (1991) Heterogeneity in the inheritance of alcoholism: A study of male and female twins. Arch Gen Psychiatry 48:19-28.
91. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor and antagonist into the central nucleus of the amygdala reverses angiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32.
92. Reich W, Earls F, Frankel O, Shayka JJ (1993) Psychopathology in children of alcoholics. J Am Acad Child Adolesc Psychiatry 32:995-1002.
93. Richter RM, Pich EM, Koob GF, Weiss F (1995) Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187:169-172.
94. Robins LN, Regier DA (1991) Psychiatric disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press.
95. Rossetti ZL, Melis F, Carboni S, Gessa GL (1992) Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: A common neurochemical substrate for drug dependence. Ann NY Acad Sci 654:513-516.
96. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43-51.
97. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE (1987) Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 44:505-513.
98. Rounsaville BJ, Weissman MM, Kleber H, Wilber C (1982) Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 39:161-168.
99. Roy A, Virkkunen M, Linnoila M (1987) Reduced central serotonin turnover in a subgroup of alcoholics? Prog Neuro-Psychopharmacol Biol Psychiatry 11:173-177.
100. Satel SL, Kosten TR, Schuckit MA, Fischman MW (1993) Should protracted withdrawal be included in DSM-IV? Am J Psychiatry 150:695-704.
101. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD (1991) Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. Am J Psychiatry 148:1712-1716.
102. Schuckit MA (1986) Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 143:140-147.
103. Schuckit MA (1994) Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151:184-189.
104. Stockmeier CA, Martino AM, Kellar KJ (1985) A strong influence of serotonin axons on beta-adrenergic receptors in rat brain. Science 230:323-325.
105. Swerdlow NR, Koob GF (1987) Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatal-pallidothalamic function. Behav Brain Sci 10:197-245.
106. Targum SD, Wheadon DE, Chastek CT, McCabe WJ, Advani MT (1982) Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients. J Affect Dis 4:347-353.
107. Titievsky J, Seco G, Barranco M, Kyle EM (1982) Doxepin as adjunctive therapy for depressed methadone maintenance patients: A double-blind study. J Clin Psychiatry 43:454-456.
108. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R, Eaves L (1996) Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs. Am J Med Genet 67:473-477.
109. Turkka J, Gurguis G, Karanian J, Potter WZ, Linnoila M (1990) Effects of chronic exposure to ethanol alone and in combination with desipramine on β-adrenoceptors of rat brain. Eur J Pharmacol 177:171-179.
110. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D (1990) Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147:719-724.
111. Von Knorring AL, Cloninger CR, Bohman M, Sigvardsson S (1983) An adoption study of depressive disorders and substance abuse. Arch Gen Psychiatry 40:943-950.
112. Wahlestedt C, Blendy JA, Kellar KJ, Heilig M, Widerlov E, Ekman R (1990) Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)- like immunoreactivity in the rat. Brain Res 507:65-68.
113. Wang RY, Aghajanian GK (1980) Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment. Commun Psychopharmacol 4:83-90.
114. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS (1990) Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: A controlled, residential study. Arch Gen Psychiatry 47:861-868.
115. Weddington WW, Brown BS, Haertzen CA, Hess JM, Mahaffey JR, Kolar AF, Jaffe JH (1991) Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 17:137-152.
116. Weiss F, Markou A, Lorang MT, Koob GF (1992a) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318.
117. Weiss F, Paulus MP, Lorang MT, Koob GF (1992b) Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: Effects of acute and repeated administration. J Neurosci 12:4372-4380.
118. Weiss RD, Mirin SM, Griffin ML (1992) Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict 87:179-187.
119. Weiss RD, Mirin SM, Griffin ML, Michael JL (1988) Psychopathology in cocaine abusers: Changing trends. J Nerv Ment Dis 176(12):719-725.
120. Weiss RD, Mirin SM, Michael JL, Sollogub AC (1986) Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse 12:17-29.
121. Weiss F, Parsons LH, Lorang MT, Hyytia P, Schulteis G, Koob GF (1994) Ethanol self-administration in dependent rats: Effects on dopamine and serotonin release in the nucleus accumbens. Annual Meeting of the Research Society on Alcoholism (RSA), Maui, Hawaii.
122. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I (1986) Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 43:923-929.
123. Widerlov E, Lindstrom LH, Wahlestedt C, Ekman R (1988) Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22:69-79.
124. Willner P (1985) Antidepressants and serotonergic neurotransmission: An integrative review. Psychopharmacology 85:387-404.
125. Willner P, Lappas S, Cheeta S, Muscat R (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology 115:454-462.
126. Woody GE, O'Brien CP, McLellan AT, Marcovici M, Evans BD (1982) The use of antidepressants with methadone in depressed maintenance patients. Ann NY Acad Sci 398:120-127.
127. Woody GE, O'Brien CP, Rickels K (1975) Depression and anxiety in heroin addicts: A placebo-controlled study of doxepin in combination with methadone. Am J Psychiatry 132:447-450.
128. Ziedonis DM, Kosten TR (1991) Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 27:337-343.
129. Zisook S, Schuckit MA (1987) Male primary alcoholics with and without family histories of affective disorder. J Stud Alcohol 48:337-344.